Amgen's Repatha Pricing Deal With Harvard Pilgrim Hinges On Results, Utilization
This article was originally published in The Pink Sheet Daily
Executive Summary
Additional discounts kick in if patients don't achieve same LDL cholesterol reduction seen in clinical trials and if utilization is excessive.